The Column Group LLC
- SEC CIK
- 0001833486
- Latest filing
- Aug 14, 2026
Holdings in Q3 2023
Holdings as of Sep 30, 2023, filed Nov 13, 2023. Long positions only; changes compare share counts with Q2 2023.
- Positions
- 7
- 0 vs. Q2 2023
- Portfolio value
- $150.6M
- −$107.1M (−41.5%) vs. Q2 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RAPTRAPT Therapeutics, Inc. | COM | 2,680,621 | $44.6M | 29.6% | 00.0% | Unchanged | History |
| RVMDRevolution Medicines, Inc. | COM | 1,230,641 | $34.1M | 22.6% | −1,346,579−52.2% | Reduced | History |
| TNYATenaya Therapeutics, Inc. | COM | 9,400,290 | $24.0M | 15.9% | 00.0% | Unchanged | History |
| ORICOric Pharmaceuticals, Inc. | COM | 3,568,181 | $21.6M | 14.3% | 00.0% | Unchanged | History |
| NGMNGM Biopharmaceuticals Inc | COM | 18,136,735 | $19.4M | 12.9% | 00.0% | Unchanged | History |
| SRZNSurrozen, Inc. | COM | 9,414,795 | $4.61M | 3.1% | 00.0% | Unchanged | History |
| EFTReFFECTOR Therapeutics, Inc. | COM | 4,026,224 | $2.42M | 1.6% | −283,105−6.6% | Reduced | History |